Correction to "Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy"

ACS Omega. 2023 Dec 20;9(1):2012. doi: 10.1021/acsomega.3c09291. eCollection 2024 Jan 9.

¹ School of Pharmacy, Biodiscovery Institute, The University of Nottingham, University Park, Nottingham NG7 2RD, U.K.
² School of Chemistry, Biodiscovery Institute, The University of Nottingham, University Park, Nottingham NG7 2RD, U.K.
³ The University of Nottingham Malaysia, Block B, Malaysia Campus, Jalan Broga, 43500 Semenyih, Selangor, Malaysia.
⁴ Department of Chemistry, Faculty of Science, The University of Malaya, 50603 Kuala Lumpur, Malaysia.
⁵ Faculty of Engineering, The University of Nottingham, Additive Manufacturing Building, Jubilee Campus, University Park, Nottingham NG7 2RD, U.K.

Abstract

[This corrects the article DOI: 10.1021/acsomega.2c00997.].